Form 10-Q AOXING PHARMACEUTICAL For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
- Twilio, Vylor set to join S&P 500 as index reshuffles members
Aoxing Pharmaceutical (AXN) Reports Q2 EPS of $0.03
February 8, 2016 8:33 AM ESTAoxing Pharmaceutical (NYSE: AXN) reported Q2 EPS of $0.03, versus $0.01 reported last year. Revenue for the quarter came in at $8.2 million, versus $6.4 million reported last year.
For earnings history and earnings-related data on Aoxing Pharmaceutical (AXN) click here.
... More